Lionel Uwer
Vandoeuvre-les-nancy, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Eribulin efficacy in long responder patients with metastatic breast cancer: A multicentric observational study.
Journal: Cancer epidemiology
Published: November 20, 2024
Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer.
Journal: British journal of cancer
Published: March 31, 2024
Real-world clinical and survival outcomes of patients with early relapsed triple-negative breast cancer from the ESME national cohort.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 04, 2023
Real-World Impact of Adjuvant Anti-HER2 Treatment on Characteristics and Outcomes of Women With HER2-Positive Metastatic Breast Cancer in the ESME Program.
Journal: The oncologist
Published: February 11, 2023
Long-Term Results with Everolimus in Advanced Hormone Receptor Positive Breast Cancer in a Multicenter National Real-World Observational Study.
Journal: Cancers
Published: December 10, 2022
Efficacy of front-line treatment for hormone receptor-positive HER2-negative metastatic breast cancer with germline BRCA1/2 mutation.
Journal: British journal of cancer
Published: October 13, 2022
Clinical outcome of patients with isolated central nervous system progression on first-line pertuzumab and trastuzumab treatment for HER2-positive metastatic breast cancer in a real-life cohort.
Journal: Breast cancer (Tokyo, Japan)
Published: October 12, 2022
Comparison of Management and Outcomes in ERBB2-Low vs ERBB2-Zero Metastatic Breast Cancer in France.
Comparison of Management and Outcomes in ERBB2-Low vs ERBB2-Zero Metastatic Breast Cancer in France.
Journal: JAMA network open
Published: September 15, 2022
Association between progression-free survival and overall survival in women receiving first-line treatment for metastatic breast cancer: evidence from the ESME real-world database.
Journal: BMC medicine
Published: July 04, 2022
Efficacy of taxanes rechallenge in first-line treatment of early metastatic relapse of patients with HER2-negative breast cancer previously treated with a (neo)adjuvant taxanes regimen: A multicentre retrospective observational study.
Journal: Breast (Edinburgh, Scotland)
Published: June 08, 2022
Survival outcomes of metastatic breast cancer patients by germline BRCA1/2 status in a large multicenter real-world database.
Journal: International journal of cancer
Published: April 05, 2022
Corrigendum to "De novo metastatic breast cancer in patients with a small locoregional tumour (T1-T2/N0): characteristics and prognosis" [Eur J Cancer 158 (2021) 181-188].
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 22, 2022
Last Updated: 09/26/2026